Thomas Mourez

ORCID: 0000-0001-6173-2908
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • Hepatitis C virus research
  • Virology and Viral Diseases
  • Viral gastroenteritis research and epidemiology
  • Respiratory viral infections research
  • Animal Virus Infections Studies
  • Hepatitis B Virus Studies
  • Immune Cell Function and Interaction
  • Herpesvirus Infections and Treatments
  • Full-Duplex Wireless Communications
  • Polyomavirus and related diseases
  • Cytomegalovirus and herpesvirus research
  • Hepatitis Viruses Studies and Epidemiology
  • Viral Infectious Diseases and Gene Expression in Insects
  • SARS-CoV-2 and COVID-19 Research
  • Bacterial Infections and Vaccines
  • Infectious Encephalopathies and Encephalitis
  • Liver Disease Diagnosis and Treatment
  • Energy Harvesting in Wireless Networks
  • Viral Infections and Vectors
  • Virus-based gene therapy research
  • Pneumocystis jirovecii pneumonia detection and treatment
  • Advanced Biosensing Techniques and Applications

Université de Caen Normandie
2005-2024

Université de Rouen Normandie
2013-2024

Normandie Université
2013-2024

Inserm
2022-2024

Centre Hospitalier Universitaire de Rouen
2013-2019

Centre de Physiopathologie de Toulouse-Purpan
2018

Institute for Research and Innovation in Biomedicine
2013-2017

Institut de Recherche et d’Innovation
2013-2016

Hôpital Charles-Nicolle
2012-2016

Institut Pasteur
2009-2011

Abstract The human coronavirus NL63 (HCoV-NL63) was first identified in the Netherlands, and its circulation France has not been investigated. We studied HCoV-NL63 infection hospitalized children diagnosed with respiratory tract infections. From November 2002 to April 2003, we evaluated 300 specimens for HCoV-NL63. Of samples, 28 (9.3%) were positive highest prevalence found February (18%). main symptoms fever (61%), rhinitis (39%), bronchiolitis digestive problems (33%), otitis (28%),...

10.3201/eid1108.050110 article EN cc-by Emerging infectious diseases 2005-08-01

The 2 groups of human coronaviruses (HCoVs) represented by the prototype strains HCoV 229E and OC43 are mostly known as viruses responsible for common cold syndrome. HCoVs difficult to detect, epidemiological data rare. From October 2000 through April 2001, we tested 1803 respiratory samples reverse-transcriptase polymerase chain reaction. 8 February 27 March was detected in obtained from 30 (6%) 501 patients. other were syncytial virus (6.1%), parainfluenza 3 (1%), influenza A (7.8%), B...

10.1086/374222 article EN other-oa Clinical Infectious Diseases 2003-04-15

Polyomaviruses KI (KIPyV) and WU (WUPyV) were recently identified, mainly in respiratory specimens from children. Among 200 patients with disorders admitted to Saint Louis Hospital, Paris, France, KIPyV was detected 8% WUPyV 1%. significantly more frequent among human stem cell transplant (17.8% vs. 5.1%; p = 0.01).

10.3201/1501.080758 article EN cc-by Emerging infectious diseases 2008-12-30

BK virus (BKV)-associated diseases in transplant recipients are an emerging issue. However, identification of the various subtypes/subgroups is a long and delicate process on basis currently available data. Therefore, we wanted to define simple effective one-step strategy for characterizing all strains from VP1 gene sequence. Based analysis 199 complete DNA sequences, phylogenetic trees, alignments, isolated polymorphisms were used distinguishing 12 different subtypes/subgroups. subtypes...

10.1128/jcm.01180-16 article EN Journal of Clinical Microbiology 2017-02-02

Abstract Polyomaviruses KI (KIPyV) and WU (WUPyV) were recently identified, mainly in respiratory specimens from children. Among 200 patients with disorders admitted to Saint Louis Hospital, Paris, France, KIPyV was detected 8% WUPyV 1%. significantly more frequent among human stem cell transplant (17.8% vs. 5.1%; p = 0.01).

10.3201/eid1501.080758 article EN cc-by Emerging infectious diseases 2009-01-01

Objective: To evaluate the quantification performance of new Cepheid GeneXpert HIV-1 viral load assay, on a wide panel variants. Methods: Clinical was evaluated relative to Abbott RealTime assay 285 seropositive samples selected cover assays range (40 copies/mL–10,000,000 copies/mL), and included RNA undetectable or detected samples. The comprised 120 subtype B, 150 non-B, 15 nontypable clinical samples; serial dilutions 18 supernatants representative divergent viruses groups N, O, P were...

10.1097/qai.0000000000001003 article EN JAIDS Journal of Acquired Immune Deficiency Syndromes 2016-03-23

Objective: Despite the genetic divergence between HIV-1 groups M and O, M/O intergroup recombinants were reported. Actually, there is no data on transmissibility of such recombinant forms. During a surveillance HIV diversity in Cameroon, we investigated possible direct transmission an virus HIV-infected couple. Methods: Consecutive samples obtained from couple analysed for detection dual O infections, Analyses performed using serological molecular algorithm based serotyping group-specific...

10.1097/qad.0000000000000880 article EN AIDS 2015-09-29

Due to the prevalence of HIV-1 group M and endemicity O infections in Cameroon, patients may be infected with both viruses and/or HIV-1/MO recombinant forms. Such atypical deleterious terms diagnosis therapeutic management due high divergence HIV-1/O. The aim this study was identify prospectively such Cameroon.Based on serological screening by env-V3 serotyping a molecular strategy using group-specific (RT)-PCRs, we identified 10 Cameroonian harboring three different profiles infection: (1)...

10.1186/s12977-016-0324-3 article EN cc-by Retrovirology 2017-01-13
Stéphanie Raymond François Nicot Coralie Pallier Pantxika Bellecave Anne Maillard and 95 more Mary‐Anne Trabaud Laurence Morand‐Joubert Audrey Rodallec Corinne Amiel Thomas Mourez Laurence Bocket Agnès Beby‐Defaux Magali Bouvier–Alias Sidonie Lambert‐Niclot Charlotte Charpentier Brice Malve Audrey Mirand Julia Dina Hélène Le Guillou‐Guillemette Stéphanie Marque‐Juillet Anne Signori-Schmück Francis Barin Ali Si‐Mohamed Véronique Avettand-Fènoël Catherine Roussel Vincent Cálvez Karine Sauné Anne‐Geneviève Marcelin Christophe Rodriguez Diane Descamps Jacques Izopet E. Lagier Catherine Roussel Hélène Le Guillou‐Guillemette C Alloui Dominique Bettinger C. Pallier Heloísa Junqueira Fleury Sandrine Reigadas Pantxika Bellecave Patricia Recordon‐Pinson Christopher Payan Sophie Vallet Astrid Vabret J. Dina Cécile Henquell Audrey Mirand Magali Bouvier–Alias Alexis de Rougemont Georges Dos Santos Patrice Morand Anne Signori-Schmück Laurence Bocket Sylvie Ranger‐Rogez Patrice André J. C. Tardy Mary‐Anne Trabaud Catherine Tamalet Catherine Delamare Brigitte Montès Évelyne Schvoerer V Ferré E André-Garnier J Cottalorda Jérôme Guinard A. Guiguon Diane Descamps Françoise Brun‐Vézinet C. Charpentier Benoît Visseaux Gilles Peytavin Anne Krivine Ali Si‐Mohamed Véronique Avettand-Fènoël Anne‐Geneviève Marcelin Vincent Cálvez Sidonie Lambert-Niclot Cathia Soulié Marc Wirden Laurence Morand‐Joubert Constance Delaugerre Marie‐Laure Chaix Corinne Amiel Véronique Schneider G. Giraudeau A. Beby Defaux Véronique Brodard Anne Maillard Jean‐Christophe Plantier C. Chaplain Thomas Bourlet Samira Fafi‐Kremer Françoise Stoll‐Keller Marie‐Paule Schmitt Hubert Barth Sabine Yerly Cécile Poggi Jacques Izopet Stéphanie Raymond Francis Barin

Minority resistant variants of human immunodeficiency virus type 1 (HIV-1) could influence the virological response to treatment based on nonnucleoside reverse transcriptase inhibitors (NNRTIs). Data minority rilpivirine-resistant are scarce. This study used next-generation sequencing (NGS) identify patients harboring nucleos(t)ide and NNRTIs assess their (VR).All subjects, 541 HIV-1-infected started a first-line regimen containing rilpivirine. VR was defined as HIV-1 RNA load <50 copies/mL...

10.1093/cid/cix1070 article EN Clinical Infectious Diseases 2017-12-12

ABSTRACT The pretherapeutic presence of protease inhibitor (PI) resistance-associated variants (RAVs) has not been shown to be predictive triple-therapy outcomes in treatment-naive patients. However, they may influence the outcome patients with less effective pegylated interferon (pegIFN)-ribavirin (RBV) backbones. Using hepatitis C virus (HCV) population sequence analysis, we retrospectively investigated prevalence baseline nonstructural 3 (NS3) RAVs a multicenter cohort poor IFN-RBV...

10.1128/jcm.03633-14 article EN Journal of Clinical Microbiology 2015-04-30

Rapid tests for HIV testing are essential tools to achieve the 90-90-90 target of World Health Organization. Many available, some directly from websites. Evaluation performance rapid tests, under close real-life usage, is therefore needed ensure accurate diagnosis in context recommendation their more widespread use.Nine third- (3G) or fourth-generation (4G) screening self-tests (two bought on websites), were evaluated an extensive panel 200 HIV-negative and 312 HIV-positive samples,...

10.1016/j.ebiom.2018.10.012 article EN cc-by-nc-nd EBioMedicine 2018-10-24

To describe integrase strand transfer inhibitor (INSTI) resistance profiles and factors associated with in antiretroviral-naive -experienced patients failing an INSTI-based regimen clinical practice.Data were collected from INSTI-containing a multicentre French study between 2014 2017. Failure was defined as two consecutive plasma viral loads (VL) >50 copies/mL. Reverse transcriptase, protease coding regions sequenced at baseline failure. INSTI resistance-associated mutations (RAMs) included...

10.1093/jac/dkz021 article EN Journal of Antimicrobial Chemotherapy 2019-01-10

Fostemsavir belongs to the new class of attachment inhibitors (AIs); it inhibits entry HIV into CD4+ T-lymphocytes by blocking conformational changes in gp120. This is a promising AI, but previous phenotypic data showed that genetically divergent HIV-1 group O could present natural resistance this drug. These were obtained from only two strains, which are not representative high intra-group genetic diversity. Moreover, no available concerning other groups (N and P). To further investigate...

10.1093/jac/dky271 article EN Journal of Antimicrobial Chemotherapy 2018-06-25

A number of paramyxoviruses are responsible for acute respiratory infections in children, elderly and immuno-compromised individuals, resulting airway inflammation exacerbation chronic diseases like asthma. To understand the molecular pathogenesis these infections, we searched cellular targets virulence protein C human parainfluenza virus type 3 (hPIV3-C). We found that hPIV3-C interacts directly through its C-terminal domain with STAT1 GRB2, whereas proteins from measles or Nipah viruses...

10.1371/journal.ppat.1000587 article EN cc-by PLoS Pathogens 2009-09-18

Human immunodeficiency virus (HIV) load is the main marker used to monitor antiviral treatment efficacy and resistance. We report a case of underquantification HIV type 1 (HIV-1) RNA in plasma cerebrospinal fluid from an HIV-1 subtype G-infected woman, leading delayed diagnosis encephalitis emergence drug

10.1128/jcm.00206-09 article EN Journal of Clinical Microbiology 2009-09-17

Human coronavirus OC43 (HCoV-OC43) causes acute, self-limited respiratory infections. A close relationship between bovine coronaviruses (BCoVs) and HCoV-OC43 has recently been demonstrated. This study includes seven clinical, non-cell culture-adapted, contemporary strains detected in France 2003. By using RT-PCR clonal sequencing of the S1 gene HCoV-OC43, inter-variant heterogeneity circulating was studied intra-variant diversity assessed by investigation a quasispecies cloud. paper brings...

10.1099/vir.0.82065-0 article EN Journal of General Virology 2006-10-09

Background: The broad genetic divergence of HIV-1/O relative to HIV-1/M has important implications for diagnosis, monitoring and treatment. Despite this divergence, some HIV-1/M+O dual infections HIV-1/MO recombinant forms have been reported, mostly in Cameroon, where both groups are prevalent. Here, we describe the characteristics such detected France 10 new patients, discuss their biological clinical practice, owing presence group O species. Methods: French National Reference Centre HIV...

10.1097/qad.0000000000001814 article EN AIDS 2018-04-20
Coming Soon ...